Citius oncology engages jefferies as exclusive financial advisor to explore strategic alternatives

Cranford, n.j. , jan. 6, 2025 /prnewswire/ -- citius oncology, inc. ("citius oncology" or "the company") (nasdaq: ctor), a majority-owned subsidiary of citius pharmaceuticals, inc. ("citius pharma") (nasdaq: ctxr), today announced that it has retained jefferies llc as its exclusive financial advisor to assist in evaluating strategic alternatives aimed at maximizing shareholder value.
CTXR Ratings Summary
CTXR Quant Ranking